Piramal Pharma Ltd. - Research Center
543635 PPLPHARMA Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Sales | 1,284.39 | 1,063.20 | 1,525.30 | 1,024.14 | 994.24 |
| Operating profit | 252.89 | 151.63 | 389.64 | 125.53 | 86.16 |
| Interest | 29.95 | 24.88 | 27.66 | 17.42 | 28.22 |
| Gross profit | 329.32 | 163.51 | 415.17 | 141.22 | 147.02 |
| EPS (Rs) | 1.59 | 0.64 | 2.06 | 0.56 | 0.58 |
Quarterly
results in details
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Other income | 106.38 | 36.76 | 53.19 | 33.11 | 89.08 |
| Stock adjustment | -71.41 | -132.35 | 135.74 | -120.72 | -11.59 |
| Raw material | 380.22 | 405.76 | 417.52 | 444.94 | 356.76 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 176.72 | 186.96 | 152.88 | 150.56 | 151.44 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 545.97 | 451.20 | 429.52 | 423.83 | 411.47 |
| Provisions made | - | - | - | - | - |
| Depreciation | 53.61 | 51.85 | 52.50 | 51.56 | 50.83 |
| Taxation | 65.65 | 26.39 | 89.59 | 15.32 | 19.03 |
| Net profit / loss | 210.06 | 85.27 | 273.08 | 74.34 | 77.16 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 1,323.14 | 1,322.95 | 1,322.95 | 1,322.95 | 1,322.95 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.69 | 14.26 | 25.55 | 12.26 | 8.67 |
| GPM (%) | 23.68 | 14.87 | 26.30 | 13.36 | 13.57 |
| NPM (%) | 15.10 | 7.75 | 17.30 | 7.03 | 7.12 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis